Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05369000
Title Trial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Lava Therapeutics
Indications

prostate cancer

castration-resistant prostate carcinoma

Therapies

LAVA-1207

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.